Jump to content
This site uses cookies. Continued use is acceptance of our Terms of Use and Privacy Policy. More Info... ×
  • Welcome to Celiac.com!

    You have found your celiac tribe! Join us and ask questions in our forum, share your story, and connect with others.




  • Celiac.com Sponsor (A1):



    Celiac.com Sponsor (A1-M):


  • Get Celiac.com Updates:
    Support Our Content
    eNewsletter
    Donate
  • Scott Adams
    Scott Adams

    Study Shows IgA tTG Testing for Celiac Disease is Less Sensitive than Believed

    Reviewed and edited by a celiac disease expert.

    Verification bias means IgA tissue transglutaminase (tTG) testing for celiac disease is less sensitive than previously believed, say researchers.

    Study Shows IgA tTG Testing for Celiac Disease is Less Sensitive than Believed - Unclear future. Image: CC BY 2.0--mripp
    Caption: Unclear future. Image: CC BY 2.0--mripp

    Celiac.com 05/04/2021 - Immunoglobulin A tissue transglutaminase gives doctors a noninvasive way to spot celiac disease, but new research suggests that its sensitivity may be lower than estimated, making it a poor screening test, at least in asymptomatic patients. 

    The reason comes down to verification bias, wherein a technique appears to have higher sensitivity and lower specificity than it actually does, because individuals who screen positive are more likely to have their disease confirmed by a follow-up small-bowel biopsy, while those who screen negative are unlikely to have a follow-up biopsy that could reveal missed celiac disease.

    Celiac.com Sponsor (A12):
    That matters because the disparity could lead to missed celiac diagnoses, because some of those in the negative group could actually have celiac disease.

    "What you're missing from when you're calculating sensitivity is, what about the ones that are negative on the index test? Would they have been positive on that reference test? That's not even coming into your calculation because they're not getting that reference test," said Marisa Stahl, MD, a physician and researcher at the Children's Hospital Colorado Center of Celiac Disease in Aurora. Stahl was not involved in the meta-analysis, but commented on it in an interview.

    To determine whether the studies used by USPSTF may have overestimated sensitivity due to verification bias, Isabel Hujoel, MD, of the Mayo Clinic, Rochester, Minn., and colleagues conducted a meta-analysis, in which they reviewed those same nine studies to see the potential impact of verification bias. They then rated each  study as being high, low, or unclear for possible verification bias. In all, they found five studies to be high risk.

    The only way to fully correct the bias is to run both IgA tissue transglutaminase (tTG) testing and small bowel biopsy on a complete or random sample of patients, and compare the sensitivity and specificity of IgA tTG with the preferred method small-bowel biopsy. But this is almost never done. 

    Instead, when the U.S. Preventive Services Task Force concluded that evidence was insufficient for IgA tTG testing for celiac disease, it relied on a 2016 comparative effectiveness review of nine studies that estimated sensitivity at 92.6% and specificity at 97.6%. 

    USPSTF remained noncommittal because of inadequate evidence surrounding the balance of benefit and harms of screening for celiac disease in asymptomatic individuals.

    Dr. Stahl was a bit shocked to see that the sensitivity was so much lower than has been traditionally accepted. The data clearly shows that "...the sensitivity is probably lower than what we oftentimes reference, and we should think more about the population of patients that could potentially screen negative and still have celiac disease," she said. 

    Stahl suggests that the problem may be more common in adults, who have a higher incidence of seronegative Celiac disease, though there is no good data on that point, right now.

    Clearly reduced sensitivity of IgA tissue transglutaminase (tTG) testing is a big deal, and we're likely to hear more on this, so stay tuned.

    Read the full report in the Journal of Clinical Gastroenterology and the abstract pubmed.ncbi.nlm.nih.gov



    User Feedback

    Recommended Comments

    Guest Sam

    Posted

    Here is a link to the abstract of the article, rather than another editorial on the article: https://pubmed.ncbi.nlm.nih.gov/32433257/.  It is also interesting to note that while they found a lower than expected sensitivity, the specificity actually increased.

    Link to comment
    Share on other sites
    trents

    It would seem then we are throwing weight back to the importance of the endoscopy/biopsy, since there was a trend to rely only on the blood tests. Just seems to be common sense to me that testing for a disease in multiple ways is going to be a more reliable diagnostic methodology. 

    Link to comment
    Share on other sites
    Rebmes

    Both my father and I have a lot of pains, a lot of the time, for most of our lives, but both of us have completely recovered since we eliminated gluten from our diets. He did it first, and saw great success, but it took about a year. I did it more recently because my wife was diagnosed with Celiac's and we always eat together (she's quite severe and we had to eliminate all gluten from the household) and saw the same results. I live with a looooot less pain now. I had the blood test done when I was still consuming gluten regularly, and tested negative.

    My dad and I theorize that we have some sort of sensitivity to gluten, but perhaps we just have a less advanced, or less symptomatic Celiac's disease that was missed by my blood test. Scary!

    Link to comment
    Share on other sites
    Wheatwacked

    "These findings suggest caution in the interpretation of a negative IgA tTG to rule out celiac disease in clinical practice."

    That's still 50% fewer people who need biopsy to diagnose positive. 

    Link to comment
    Share on other sites


    Create an account or sign in to comment

    You need to be a member in order to leave a comment

    Create an account

    Sign up for a new account in our community. It's easy!

    Register a new account

    Sign in

    Already have an account? Sign in here.

    Sign In Now

  • Get Celiac.com Updates:
    Support Celiac.com:
    Donate
  • About Me

    Scott Adams

    Scott Adams was diagnosed with celiac disease in 1994, and, due to the nearly total lack of information available at that time, was forced to become an expert on the disease in order to recover. In 1995 he launched the site that later became Celiac.com to help as many people as possible with celiac disease get diagnosed so they can begin to live happy, healthy gluten-free lives.  He is co-author of the book Cereal Killers, and founder and publisher of the (formerly paper) newsletter Journal of Gluten Sensitivity. In 1998 he founded The Gluten-Free Mall which he sold in 2014. Celiac.com does not sell any products, and is 100% advertiser supported.


  • Celiac.com Sponsor (A17):
    Celiac.com Sponsor (A17):





    Celiac.com Sponsors (A17-M):




  • Related Articles

    Jefferson Adams
    Celiac.com 08/26/2015 - People with IgA antibodies to tissue transglutaminase (anti-tTg) likely have a higher risk for celiac disease. Some clinicians and researchers have suggested that common multiples of the upper limit of normal (ULN) be useful tool in improving diagnostic pathways, as well as continuity between tests.
    However, a new study suggests that both sensitivity and specificity of tests for IgA antibodies to tissue transglutaminase vary widely by individual kit, and that their test values are not easily commutable using common multiples of the ULN to correct for inter-assay variations. Commutability just means the ability to make sure that two different tests really are equal. If results of different tests are commutable, it means that they are equal. In this case, the term...


    Jefferson Adams
    Does IgA tTG Predict Mucosal Recovery in Children with Celiac Disease on a Gluten Free Diet?
    Celiac.com 01/23/2017 - It makes some kind of sense that kids with celiac disease who follow a gluten-free diet will recover, their guts will normalize, and their levels of IgA tissue transglutaminase antibodies would drop to reflect this change; whereas high antibodies likely mean no recovery, right? But is that true? Is there really a correlation on any level?
    To test this idea, a team of researchers recently set out to document the rate of mucosal recovery in kids with celiac disease on a gluten-free diet. They also wanted to figure out whether IgA tissue transglutaminase (tTG) correlates with mucosal damage at the time of a repeat endoscopy with duodenal biopsy.
    The research team included Maureen M. Leonard, Dascha C. Weir, Maya DeGroote, Paul D. Mitchell, Prashant Singh, Jocelyn...


    Jefferson Adams
    Can Undetectable Negative Tissue Transglutaminase IgA antibodies Predict Mucosal Healing in Treated Celiac Disease Patients?
    Celiac.com 10/13/2017 - Tissue transglutaminase (tTG) immunoglobulin A (IgA) testing is a sensitive adjunct to the diagnosis of coeliac disease. The threshold for positivity was developed for diagnosis, with negative results reported as below the reference value (<4 U/mL).
    A team of researchers recently set out to investigate if an undetectable tissue transglutaminase IgA antibodies (tTG IgA<1.2 U/mL) is more predictive of healing compared to patients with negative but detectable serology (1.2-3.9 U/mL).
    The research team included H. Fang, K. S. King, J. J. Larson, M. R. Snyder, T. T. Wu, M. J. Gandhi, and J. A. Murray. They are variously affiliated with the Department of Medicine, the Division of Gastroenterology and Hepatology, the Division of Anatomic Pathology, the Division...


    Scott Adams
    Anti-tissue Transglutaminase Antibodies May Be Associated with Cow's Milk Protein in Addition to Gluten Intake
    Celiac.com 02/08/2021 - Anti-tissue transglutaminase antibodies (tTG) are a strong indicator of celiac disease, but positive anti-tTG antibodies have also been reported in some non-celiac patients. A team of researchers recently set out to examine positive anti-tTG antibodies that are not related to gluten intake.
    The research team included Mónica Garcia-Peris, Ester Donat Aliaga, María Roca Llorens, Etna Masip Simó, Begoña Polo Miquel, and Carmen Ribes Koninck.
    They are variously affiliated with the Pediatric Service, Lluís Alcanyís Hospital, Xàtiva (Valencia), Spain; the Pediatric Gastroenterology Unit, Hospital Universitari i Politécnic La Fe, Valencia, Spain; and the Celiac Disease and Digestive Immunopathology Unit, Instituto de Investigación Sanitaria La Fe in Valenc...


  • Recent Activity

    1. - cristiana replied to sh00148's topic in Celiac Disease Pre-Diagnosis, Testing & Symptoms
      2

      Nighttime Soiling (5 year old)

    2. - Scott Adams replied to Blue Roan's topic in Related Issues & Disorders
      2

      Lymph nodes in neck + thyroid issues

    3. - Scott Adams replied to StrongerThanCeliac's topic in Post Diagnosis, Recovery & Treatment of Celiac Disease
      1

      2 Separate Glutenings - Recovery Timeline?

    4. - Scott Adams replied to Therockfrog's topic in Related Issues & Disorders
      2

      Itchy skin, tingling in feet and scalp


  • Celiac.com Sponsor (A19):



  • Member Statistics

    • Total Members
      125,785
    • Most Online (within 30 mins)
      7,748

    bjboudreau
    Newest Member
    bjboudreau
    Joined

  • Celiac.com Sponsor (A20):


  • Forum Statistics

    • Total Topics
      120.8k
    • Total Posts
      68.9k

  • Celiac.com Sponsor (A22):





  • Celiac.com Sponsor (A21):



  • Popular Now

    • Elliebee
    • mswhis
    • Dhruv
      20
    • Sking
    • jmiller93
      8
  • Popular Articles

    • Scott Adams
    • Scott Adams
    • Scott Adams
    • Scott Adams
    • Scott Adams
  • Upcoming Events

×
×
  • Create New...